肠道微生态理念在慢性便秘治疗中的应用研究
收稿日期: 2020-01-10
网络出版日期: 2020-04-25
基金资助
国家自然科学基金(81670493);上海市第十人民医院临床路径课题(LCLJKT1819-10)
Intestinal microenvironment as an idea in treatment of chronic constipation
田宏亮, 李宁 . 肠道微生态理念在慢性便秘治疗中的应用研究[J]. 外科理论与实践, 2020 , 25(02) : 98 -101 . DOI: 10.16139/j.1007-9610.2020.02.002
| [1] | Bharucha AE, Pemberton JH, Locke GR 3rd. American Gastroenterological Association technical review on constipation[J]. Gastroenterology, 2013, 144(1):218-238. |
| [2] | Rao SS, Rattanakovit K, Patcharatrakul T. Diagnosis and management of chronic constipation in adults[J]. Nat Rev Gastroenterol Hepatol, 2016, 13(5):295-305. |
| [3] | Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review[J]. Am J Gastroenterol, 2004, 99(4):750-759. |
| [4] | Belsey J, Greenfield S, Candy D, et al. Systematic review: impact of constipation on quality of life in adults and children[J]. Aliment Pharmacol Ther, 2010, 31(9):938-949. |
| [5] | Rao SS, Seaton K, Miller MJ, et al. Psychological profiles and quality of life differ between patients with dyssynergia and those with slow transit constipation[J]. J Psychosom Res. 2007, 63(4):441-449. |
| [6] | Dennison C, Prasad M, Lloyd A, et al. The health-related quality of life and economic burden of constipation[J]. Pharmacoeconomics, 2005, 23(5):461-476. |
| [7] | Rao SS. Constipation: evaluation and treatment of colonic and anorectal motility disorders[J]. Gastroenterol Clin North Am, 2007, 36(3):687-711. |
| [8] | Locke GR 3rd, Zinsmeister AR, Fett SL, et al. Overlap of gastrointestinal symptom complexes in a US community[J]. Neurogastroenterol Motil, 2005, 17(1):29-34. |
| [9] | American College of Gastroenterology Chronic Constipation Task Force. An evidence-based approach to the management of chronic constipation in North America[J]. Am J Gastroenterol, 2005, 100(Suppl 1):S1-S4. |
| [10] | Tack J, Muller-Lissner S, Stanghellini V, et al. Diagnosis and treatment of chronic constipation--a European perspective[J]. Neurogastroenterol Motil, 2011, 23(8):697-710. |
| [11] | Kamm MA, Mueller-Lissner S, Wald A, et al. Oral bisacodyl is effective and well-tolerated in patients with chronic constipation[J]. Clin Gastroenterol Hepatol, 2011, 9(7):577-583. |
| [12] | Gerritsen J, Smidt H, Rijkers GT, et al. Intestinal microbiota in human health and disease: the impact of probio-tics[J]. Genes Nutr, 2011, 6(3):209-240. |
| [13] | Kirgizov IV, Sukhorukov AM, Dudarev VA, et al. Hemostasis in children with dysbacteriosis in chronic constipation[J]. Clin Appl Thromb Hemost, 2001, 7(4):335-338. |
| [14] | Parthasarathy G, Chen J, Chen X, et al. Relationship between microbiota of the colonic mucosa vs feces and symptoms, colonic transit, and methane production in female patients with chronic constipation[J]. Gastroentero-logy, 2016, 150(2):367-379. |
| [15] | Vandeputte D, Falony G, Vieira-Silva S, et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates[J]. Gut, 2016, 65(1):57-62. |
| [16] | Hadizadeh F, Walter S, Belheouane M, et al. Stool frequency is associated with gut microbiota composition[J]. Gut, 2017, 66(3):559-560. |
| [17] | Rebollar E, Arruebo MP, Plaza MA, et al. Effect of lipopolysaccharide on rabbit small intestine muscle contractility in vitro: role of prostaglandins[J]. Neurogastroenterol Motil, 2002, 14(6):633-642. |
| [18] | Rondeau MP, Meltzer K, Michel KE, et al. Short chain fatty acids stimulate feline colonic smooth muscle contraction[J]. J Feline Med Surg, 2003, 5(3):167-173. |
| [19] | Reigstad CS, Salmonson CE, Rainey JF 3rd, et al. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells[J]. Faseb J, 2015, 29(4):1395-1403. |
| [20] | Zhu Y, Li F, Guo GL. Tissue-specific function of farnesoid X receptor in liver and intestine[J]. Pharmacol Res, 2011, 63(4):259-265. |
| [21] | Odunsi-Shiyanbade ST, Camilleri M, McKinzie S, et al. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function[J]. Clin Gastroenterol Hepatol, 2010, 8(2):159-165. |
| [22] | Jones BV, Begley M, Hill C, et al. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome[J]. Proc Nati Acad Sci U S A, 2008, 105(36):13580-13585. |
| [23] | Hofmann AF, Eckmann L. How bile acids confer gut mucosal protection against bacteria[J]. Proc Nati Acad Sci U S A, 2006, 103(12):4333-4334. |
| [24] | Peregrin AT, Ahlman H, Jodal M, et al. Involvement of serotonin and calcium channels in the intestinal fluid secretion evoked by bile salt and cholera toxin[J]. Br J Pharmacol, 1999, 127(4):887-894. |
| [25] | Kidd M, Modlin IM, Gustafsson BI, et al. Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants[J]. Am J Physiol Gastrointest Liver Physiol, 2008, 295(2):G260-G272. |
| [26] | Camilleri M. Bile Acid diarrhea: prevalence, pathogenesis, and therapy[J]. Gut Liver, 2015, 9(3):332-339. |
| [27] | Bunnett NW. Neuro-humoral signalling by bile acids and the TGR5 receptor in the gastrointestinal tract[J]. J Phy-siol, 2014, 592(14):2943-2950. |
| [28] | Yano JM, Yu K, Donaldson GP, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis[J]. Cell, 2015, 161(2):264-276. |
| [29] | Tan J, McKenzie C, Potamitis M, et al. The role of short-chain fatty acids in health and disease[J]. Adv Immunol, 2014, 121:91-119. |
| [30] | Koh A, de Vadder F, Kovatcheva-Datchary P, et al. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites[J]. Cell, 2016, 165(6):1332-1345. |
| [31] | Guilloteau P, Martin L, Eeckhaut V, et al. From the gut to the peripheral tissues: the multiple effects of butyrate[J]. Nutr Res Rev, 2010, 23(2):366-384. |
| [32] | Flint HJ, Scott KP, Louis P, et al. The role of the gut microbiota in nutrition and health[J]. Nat Rev Gastroenterol Hepatol, 2012, 9(10):577-589. |
| [33] | 李宁, 田宏亮. 菌群移植在肠道微生态相关疾病中的研究进展与思考[J]. 中华胃肠外科杂志, 2017, 20(10):19-23. |
| [34] | Li T, Lu X, Yang X. Stachyose-enriched alpha-galacto-oligosaccharides regulate gut microbiota and relieve constipation in mice[J]. J Agric Food Chem, 2013, 61(48):11825-11831. |
| [35] | Quigley EM. The enteric microbiota in the pathogenesis and management of constipation[J]. Best Pract Res Clin Gastroenterol, 2011, 25(1):119-126. |
| [36] | Jennings A, Davies GJ, Costarelli V, et al. Dietary fibre, fluids and physical activity in relation to constipation symptoms in pre-adolescent children[J]. J Child Health Care, 2009, 13(2):116-127. |
| [37] | López Román J, Martínez Gonzálvez AB, Luque A, et al. The effect of a fibre enriched dietary milk product in chronic primary idiopatic constipation[J]. Nutr Hosp, 2008, 23(1):12-19. |
| [38] | Derrien M, van Hylckama Vlieg JE. Fate, activity, and impact of ingested bacteria within the human gut microbiota[J]. Trends Microbiol, 2015, 23(6):354-366. |
| [39] | Ding C, Ge X, Zhang X, et al. Efficacy of synbiotics in patients with slow transit constipation: a prospective randomized trial[J]. Nutrients, 2016, 8(10).pii:E605. |
| [40] | Dimidi E, Christodoulides S, Fragkos KC, et al. The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials[J]. Am J Clin Nutr, 2014, 100(4):1075-1084. |
| [41] | Marteau P, Cuillerier E, Meance S, et al. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study[J]. Aliment Pharmacol Ther, 2002, 16(3):587-593. |
| [42] | Waller PA, Gopal PK, Leyer GJ, et al. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults[J]. Scand J Gastroenterol, 2011, 46(9):1057-1064. |
| [43] | Zhao Y, Yu YB. Intestinal microbiota and chronic constipation[J]. Springerplus, 2016, 5(1):1130. |
| [44] | Zhang FM, Luo W, Shi Y, et al. Should we Standardize the 1,700-year-old fecal microbiota transplantation?[J]. Am J Gastroenterol, 2012, 107(11):1755. |
| [45] | Eiseman B, Silen W, Bascom GS, et al. Fecal enema as an adjunct in the treatment of pseudomem branous entemcolitis[J]. Surgery, 1958, 44(5):854-859. |
| [46] | Borody TJ, George L, Andrews P, et al. Bowel-flora alte-ration: a potential cure for inflammatory bowel disease and irritable bowel syndrome[J]. Med J Aust, 1989, 150(10):604. |
| [47] | Tian H, Ge X, Nie Y, et al. Fecal microbiota transplantation in patients with slow-transit constipation: A rando-mized, clinical trial[J]. PLoS One, 2017, 12(2):e0171308. |
| [48] | 李宁, 田宏亮, 陈启仪, 等. 菌群移植治疗肠道疾病2010例疗效分析[J]. 中华胃肠外科杂志, 2019, 22(9):861-868. |
| [49] | 田宏亮, 丁超, 马春联, 等. 粪菌胶囊治疗慢传输型便秘15例临床疗效分析[J]. 中国实用外科杂志, 2016, 36?(4):430-432. |
| [50] | Camilleri M, Piessevaux H, Yiannakou Y, et al. Efficacy and safety of prucalopride in chronic constipation: an integrated analysis of six randomized, controlled clinical trials[J]. Dig Dis Sci, 2016, 61(8):2357-2372. |
| [51] | Pamer EG. Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns[J]. Mucosal Immunol, 2014, 7(2):210-214. |
/
| 〈 |
|
〉 |
